Trend of drug clinical trials in mainland China from 2009 to 2020

临床试验 医学 药品 中国大陆 内科学 重症监护医学 中国 药理学 政治学 法学
作者
Yu Cao,Lianming Liao,Xin Liu,Qingshan Zheng,Zhongyuan Xu,Haitao Niu
出处
期刊:Current Medical Research and Opinion [Taylor & Francis]
卷期号:38 (9): 1499-1507 被引量:8
标识
DOI:10.1080/03007995.2022.2103960
摘要

With the development of linnovative regulations on drug clinical trials in mainland China, the quantity and quality of drug clinical trials have gradually improved over the past decade. Based on the information of the clinical trials from the online drug clinical trial registration platform of National Medical Products Administration, we reviewed the data of drug clinical trials in mainland China from 2009 to 2020. A total of 8,593 clinical trials have been conducted during this period. The annual number of clinical trials has been increasing gradually, and peaked in 2017. There were 2,127, 1,051, 1,551, and 156 phases I, II, III, and IV clinical trials respectively. In addition, there were 3,441 bioequivalence studies. Trials for anti-tumor drugs ranked the highest (19.45%), followed by trials of drugs for infections and infestations (12.96%) and those for cardiovascular diseases (9.00%). Meanwhile the number of the clinical trial sites also increased annually. However, there were only 116 and 130 clinical trials of drugs for children and rare diseases respectively. The geographical distribution of the sites was uneven. This mapping review provides an overall look of clinical trials in China, which may be useful for domestic and international sponsors.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李健的小迷弟的应助被1x1ao采纳,获得10
刚刚
方源的应助被what采纳,获得20
刚刚
1秒前
喷火娃的应助被诺贝尔候选人采纳,获得10
1秒前
1秒前
LYP发布了新的文献求助10
2秒前
2秒前
Leo发布了新的文献求助10
2秒前
小二郎的应助被CC采纳,获得10
2秒前
HuangChuang完成签到,获得积分20
2秒前
2秒前
dzgxf发布了新的文献求助10
2秒前
在水一方的应助被Liang采纳,获得10
3秒前
3秒前
小高发布了新的文献求助10
3秒前
3秒前
4秒前
4秒前
萧楚军完成签到,获得积分20
5秒前
小蘑菇的应助被科研通管家采纳,获得30
5秒前
秋风的应助被科研通管家采纳,获得10
5秒前
pluto的应助被科研通管家采纳,获得10
6秒前
NexusExplorer的应助被科研通管家采纳,获得10
6秒前
6秒前
酷波er的应助被科研通管家采纳,获得10
6秒前
小马甲的应助被科研通管家采纳,获得10
6秒前
跳跃以山的应助被科研通管家采纳,获得10
6秒前
我是老大的应助被科研通管家采纳,获得10
6秒前
wanci的应助被科研通管家采纳,获得10
6秒前
鲤鱼白玉发布了新的文献求助10
7秒前
Lucas的应助被科研通管家采纳,获得10
7秒前
Owen的应助被科研通管家采纳,获得10
7秒前
顾矜的应助被科研通管家采纳,获得10
7秒前
搜集达人的应助被科研通管家采纳,获得10
7秒前
coldstork发布了新的文献求助10
7秒前
CodeCraft的应助被科研通管家采纳,获得10
7秒前
jianguo发布了新的文献求助10
7秒前
华仔的应助被科研通管家采纳,获得10
7秒前
7秒前
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183142
求助须知:如何正确求助?哪些是违规求助? 9572420
关于积分的说明 21825253
捐赠科研通 7779922
什么是DOI,文献DOI怎么找? 3433850
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480124